Sunil Badve
- Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
2018/06/03 by Joseph A. Sparano, Robert J. Gray, Della F. Makower +36 · 19 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Breast Cancer Treatment Studies #Advanced Breast Cancer Therapies #Breast Lesions and Carcinomas
- Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group
2016/07/01 by Carsten Denkert, Stephan Wienert, Audrey Poterie +57 · 4 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer Cells and Metastasis #Cancer Genomics and Diagnostics #Cancer Immunotherapy and Biomarkers
- Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
2017/10/12 by Maria Vittoria Dieci, Nina Radosevic‐Robin, Nina Radosevic-Robin +33 · 1 citation
Immunology and Microbiology · Medicine · #Cancer Cells and Metastasis #Cancer Immunotherapy and Biomarkers #Immunotherapy and Immune Responses
- Predicting pathologic complete response (pCR) from clinicopathologic variables and HER2DX genomic test in stage II/III HER2+ breast cancer treated with taxane, trastuzumab, and pertuzumab (THP): Secondary results from the EA1181/CompassHER2 pCR trial.
2025/05/28 by Nadine M. Tung, Nadine Tung, Fengmin Zhao +24 · 1 citation
Biochemistry, Genetics and Molecular Biology · Medicine · #Breast Cancer Treatment Studies #HER2/EGFR in Cancer Research #Lung Cancer Treatments and Mutations